BioLargo, Inc. (BLGO)
OTCMKTS · Delayed Price · Currency is USD
0.1850
-0.0020 (-1.07%)
Jul 22, 2025, 3:59 PM EDT

BioLargo Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Jul '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
575749545528
Upgrade
Market Cap Growth
-20.13%16.89%-9.01%-2.45%100.03%-22.14%
Upgrade
Enterprise Value
555244515225
Upgrade
Last Close Price
0.190.190.170.190.210.12
Upgrade
PS Ratio
3.513.224.009.1421.7911.34
Upgrade
PB Ratio
11.259.4511.6526.7559.10-117.31
Upgrade
P/TBV Ratio
7.526.467.1511.0311.857.15
Upgrade
EV/Sales Ratio
3.392.933.608.6820.6410.43
Upgrade
Debt / Equity Ratio
0.600.420.400.731.21-13.53
Upgrade
Asset Turnover
1.601.901.871.490.640.57
Upgrade
Inventory Turnover
29.6641.1044.5116.775.518.22
Upgrade
Quick Ratio
2.012.542.271.851.070.34
Upgrade
Current Ratio
2.142.702.352.001.310.43
Upgrade
Return on Equity (ROE)
-107.31%-84.75%-149.62%-348.64%-1975.36%-
Upgrade
Return on Assets (ROA)
-33.38%-28.92%-40.18%-81.37%-100.69%-109.07%
Upgrade
Return on Capital (ROIC)
-45.36%-37.31%-55.96%-115.64%-160.05%-176.69%
Upgrade
Earnings Yield
-5.50%-4.20%-7.16%-8.31%-12.84%-30.59%
Upgrade
FCF Yield
-10.29%-7.76%-5.81%-5.64%-7.18%-15.15%
Upgrade
Buyback Yield / Dilution
-3.63%-4.25%-6.58%-8.54%-26.13%-28.87%
Upgrade
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.